HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

HRX 22 - GPX Inc. CEO Javier Echenique (GPX Inc., Boston, MA, US) joins us to discuss CardioID - a novel AI Algorithm-based "bloodless blood test" that uses NT-proBNP biomarkers in patient

Digital Health

PDF) Association of Vegetable and Fruit Consumption with Urinary

HRX 22

Eliminating inpatient blood collection for clinical diagnostics by

HRX 2022: GPX Inc: Novel AI Algorithmic Blood Biomarker Monitoring

Digital Health Radcliffe Cardiology

Frontiers Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review

Digital pathology with artificial intelligence analysis provides

YMJ :: Yonsei Medical Journal

Frontiers Deep Learning-Based Automatic Assessment of Lung

Sensors, Free Full-Text

Molecules December-1 2022 - Browse Articles

PDF) Association of Vegetable and Fruit Consumption with Urinary